EMA — authorised 30 August 2018
- Marketing authorisation holder: ABLYNX NV
- Status: approved
🇪🇺 Calibvi in European Union
EMA authorised Calibvi on 30 August 2018
Marketing authorisation
Calibvi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in European Union
Frequently asked questions
Is Calibvi approved in European Union?
Yes. EMA authorised it on 30 August 2018.
Who is the marketing authorisation holder for Calibvi in European Union?
ABLYNX NV holds the EU marketing authorisation.